Nina Montgomery

Nina Montgomery serves as a primary procurement lead within the Food and Drug Administration, driving the acquisition of advanced scientific and analytical technologies critical to regulatory science and public health oversight. She manages a diverse portfolio of contracts supporting laboratory instrumentation, digital diagnostics, and automation systems that enable the FDA’s mission to ensure the safety and efficacy of medical products and food supplies. Her acquisitions focus on high-precision equipment and digital infrastructure used in drug approval processes, toxicology analysis, and real-time surveillance of health threats, aligning closely with the agency’s strategic modernization goals. Montgomery maintains longstanding partnerships with leading federal contractors including Peraton Enterprise Solutions LLC, Deloitte Consulting LLP, and Booz Allen Hamilton Inc., who provide enterprise-scale technical services, data analytics, and systems integration. She also collaborates with specialized vendors like MPF-ZAI Solutions LLC and Harvard Pilgrim Health Care Inc. to deliver niche capabilities in health data management and clinical validation frameworks. Her contracting approach emphasizes performance-based outcomes, risk mitigation, and seamless interoperability across FDA’s scientific platforms. Her procurement strategy reflects a near-equal balance between full and open competition and small business set-asides, with nearly half of her awards designated under the Total Small Business Set-Aside program (FAR 19.5). This demonstrates a strong commitment to fostering innovation through participation from small, disadvantaged, and emerging technology firms, while maintaining rigorous standards for technical capability and compliance. Montgomery’s primary NAICS focus is on Analytical Laboratory Instrument Manufacturing (334516), reflecting her deep expertise in procuring mass spectrometers, chromatography systems, and automated sample handling platforms. She also regularly acquires industrial gas systems (325120) and precision equipment maintenance services (811210), ensuring operational continuity in high-containment and regulated laboratory environments. Her domain expertise spans analytical chemistry, biosafety compliance, and digital laboratory informatics, making her a key enabler of the FDA’s scientific infrastructure.